Oxford Respiratory Trials Unit (ORTU)
The Oxford Respiratory Trials Unit (ORTU) is a Clinical Trials Unit which specialises in the design, delivery and administration of trials across the scope of Respiratory Medicine.
We run national and international trials related to our own academic areas, as well as supporting trials led by other teams. Our scope of work includes clinical trials at all phases, including translational studies, phase II discovery studies and multicentre definitive randomised trials.
We partner with a broad range of academic funders (National Institute of Health Research, Medical Research Council, British Lung Foundation, National Cancer Research Institute, CRUK) and partners in industry. Key funding for ORTU is derived from the Comprehensive Local Research Network (CLRN) and the Oxford NIHR Biomedical Research Centre.
Objective structured clinical examination in basic thoracic ultrasound: a European study of validity evidence
Pietersen PI. et al, (2023), BMC Pulmonary Medicine, 23
Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study.
Ferguson J. et al, (2023), BMJ open respiratory research, 10
Early Video Assisted Thoracoscopic Surgery (VATS) or Intrapleural Enzyme Therapy (IET) in Pleural Infection - A Feasibility Randomized Controlled Trial (The Third Multicenter Intrapleural Sepsis Trial - MIST-3).
Bedawi EO. et al, (2023), American journal of respiratory and critical care medicine
Implementable Deep Learning for Multi‐sequence Proton MRI Lung Segmentation: A Multi‐center, Multi‐vendor, and Multi‐disease Study
Astley JR. et al, (2023), Journal of Magnetic Resonance Imaging, 58, 1030 - 1044